Hot Investor Mandate 4: Venture Fund Invests in Therapeutics and Medtech in the USA & Canada

2 Feb

A venture firm with offices in Canada and the USA is investing from its second fund. The firm makes equity investments in early-stage life science companies based in Canada and the USA, and prefers to lead or co-lead investments. Initial investments will typically be of about $5 million CAD, with capital reserved for potential follow-on investments of up to $15 million CAD total per opportunity. The firm is likely to make 12-15 investments over the fund’s lifetime, with a focus on Canada; the firm also invests in the USA.

The firm will make most of its allocations in the therapeutics sector, with the remainder invested in diagnostics, medical devices, and/or tools or healthcare IT. The firm prefers to invest in early-stage opportunities; in the therapeutics sector, investments may be made in companies with a lead product 12-18 months prior to IND. The fund is generally agnostic in terms of technological field and indication area.

The firm only invests in those therapeutic companies that have identified a lead product candidate.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: